Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
ceprotin
takeda manufacturing austria ag - manna prótein c - purpura fulminans; protein c deficiency - blóðþurrðandi lyf - ceprotin is indicated for prophylaxis and treatment of purpura fulminans coumarin-induced skin necrosis and venous thrombotic events in patients with severe congenital protein c deficiency.
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
prograf hart hylki 0,5 mg
astellas pharma a/s* - tacrolimusum mónohýdrat - hart hylki - 0,5 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
prograf hart hylki 1 mg
astellas pharma a/s* - tacrolimusum mónohýdrat - hart hylki - 1 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
prograf hart hylki 5 mg
astellas pharma a/s* - tacrolimusum mónohýdrat - hart hylki - 5 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
elocon smyrsli 0,1 %
n.v. organon* - mometasonum fúróat - smyrsli - 0,1 %
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
elocon krem 0,1 %
n.v. organon* - mometasonum fúróat - krem - 0,1 %
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
elocon húðlausn 0,1 %
n.v. organon* - mometasonum fúróat - húðlausn - 0,1 %
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
seroquel prolong forðatafla 50 mg
cheplapharm arzneimittel gmbh - quetiapinum fúmarat - forðatafla - 50 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
seroquel prolong forðatafla 300 mg
cheplapharm arzneimittel gmbh - quetiapinum fúmarat - forðatafla - 300 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
seroquel prolong forðatafla 200 mg
cheplapharm arzneimittel gmbh - quetiapinum fúmarat - forðatafla - 200 mg